Search Results - "Trivedi, Hirsh D."

Refine Results
  1. 1
  2. 2

    Osteoporosis in primary biliary cholangitis by Danford, Christopher J, Trivedi, Hirsh D, Papamichael, Konstantinos, Tapper, Elliot B, Bonder, Alan

    Published in World journal of gastroenterology : WJG (21-08-2018)
    “…Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease with multiple debilitating complications. Osteoporosis is a common complication of…”
    Get full text
    Journal Article
  3. 3

    Management of pruritus in primary biliary cholangitis: a narrative review by Trivedi, Hirsh D., M.D, Lizaola, Blanca, M.D, Tapper, Elliot B., M.D, Bonder, Alan, M.D

    Published in The American journal of medicine (01-06-2017)
    “…Abstract Primary biliary cholangitis is an autoimmune condition characterized by destruction of intrahepatic bile ducts. It causes debilitating symptoms, which…”
    Get full text
    Journal Article
  4. 4

    Chronic hepatitis C infection — Noninvasive assessment of liver fibrosis in the era of direct acting antivirals by Trivedi, Hirsh D., Patwardhan, Vilas R., Malik, Raza

    Published in Digestive and liver disease (01-02-2019)
    “…Significant advancements in the diagnosis and treatment of chronic hepatitis C infection and its associated fibrosis have revolutionized treatment of these…”
    Get full text
    Journal Article
  5. 5

    Pregnancy in Chronic Liver Disease: Before and After Transplantation by Dokmak, Amr, Trivedi, Hirsh D., Bonder, Alan, Wolf, Jacqueline

    Published in Annals of hepatology (01-12-2021)
    “…Chronic liver disease poses various challenges for women of reproductive age. Cirrhosis, particularly if decompensated, and liver transplantation may impact…”
    Get full text
    Journal Article
  6. 6

    Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c by Trivedi, Hirsh D., Tran, Qua, Fricker, Zachary, Curry, Michael P., Li, Jonathan X., Lai, Michelle

    Published in Annals of hepatology (01-05-2023)
    “…The association between type 2 diabetes, non-alcoholic fatty liver disease, and liver fibrosis is well established, but it is unknown whether complications of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population by Trivedi, Hirsh D., Suri, Jaspreet, Oh, Daheun, Schwartz, Jeffrey, Goyes, Daniela, Idriss, Rajab, Curry, Michael P., Lai, Michelle

    Published in Annals of hepatology (01-09-2021)
    “…Noninvasive liver assessment in type 2 diabetes (T2DM) in a primary care population identifies higher risk non-alcoholic fatty liver disease (NAFLD). We aimed…”
    Get full text
    Journal Article
  10. 10

    Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges by Trivedi, Hirsh D, Danford, Christopher J, Goyes, Daniela, Bonder, Alan

    Published in Clinical and experimental gastroenterology (01-01-2020)
    “…Primary biliary cholangitis (PBC) is a chronic, cholestatic condition associated with symptoms that directly impact the quality of life in those afflicted with…”
    Get full text
    Journal Article
  11. 11

    Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD by Ezaz, Ghideon, Trivedi, Hirsh D., Connelly, Margery A., Filozof, Claudia, Howard, Kellie, L.Parrish, Mark, Kim, Misung, Herman, Mark A., Nasser, Imad, Afdhal, Nezam H., Jiang, Z. Gordon, Lai, Michelle

    Published in Hepatology communications (01-05-2020)
    “…Nonalcoholic fatty liver disease (NAFLD) is a heterogeneous disease driven by genetic and environmental factors. MicroRNAs (miRNAs) serve as pleiotropic…”
    Get full text
    Journal Article
  12. 12

    Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases by Nsubuga, John Paul, Goyes, Daniela, Trivedi, Hirsh D., Medina-Morales, Esli, Patwardhan, Vilas, Bonder, Alan

    Published in Journal of transplantation (04-08-2021)
    “…Background. Liver transplantation is indicated in end-stage liver disease due to autoimmune diseases. The liver allocation system can be affected by…”
    Get full text
    Journal Article
  13. 13

    The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective by Dokmak, Amr, Lizaola-Mayo, Blanca, Trivedi, Hirsh D.

    Published in The American journal of medicine (01-01-2021)
    “…Nonalcoholic fatty liver disease (NAFLD) is the leading cause of liver disease worldwide, with rising rates in parallel to those of obesity, type 2 diabetes,…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Infections in Cirrhosis: A Guide for the Clinician by Campbell, Kirsti A., Trivedi, Hirsh D., Chopra, Sanjiv

    Published in The American journal of medicine (01-06-2021)
    “…Cirrhosis contributes significantly to morbidity and mortality worldwide. Infections in patients with cirrhosis are common and significantly impact…”
    Get full text
    Journal Article
  17. 17

    MASLD/MetALD and mortality in individuals with any cardio-metabolic risk factor: a population based study with 26.7 years of follow-up by Kwak, Minsun, Kim, Hyun-Seok, Jiang, Zhenghui Gordon, Yeo, Yee Hui, Trivedi, Hirsh D, Noureddin, Mazen, Yang, Ju Dong

    Published in Hepatology (Baltimore, Md.) (13-05-2024)
    “…A new term, metabolic dysfunction-associated steatotic liver disease(MASLD), has been proposed by a multi-society expert panel. However, it remains unclear…”
    Get full text
    Journal Article
  18. 18

    Bone Health in Patients With Liver Diseases by Danford, Christopher J., Trivedi, Hirsh D., Bonder, Alan

    Published in Journal of clinical densitometry (01-04-2020)
    “…Osteoporosis is the most common bone disease in chronic liver disease (CLD) resulting in frequent fractures and leading to significant morbidity in this…”
    Get full text
    Journal Article
  19. 19

    Prognostic Models in Acute-on-Chronic Liver Failure by Goyes, Daniela, Trivedi, Hirsh D., Curry, Michael P.

    Published in Clinics in liver disease (01-08-2023)
    “…Acute-on-chronic liver failure (ACLF) is a clinical syndrome characterized by severe hepatic dysfunction leading to multiorgan failure in patients with…”
    Get full text
    Journal Article
  20. 20

    Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis by Trivedi, Hirsh D., Niezen, Sebastian, Jiang, Z. Gordon, Tapper, Elliot B.

    Published in Digestive diseases and sciences (01-08-2022)
    “…Background & Aim Liver fibrosis is associated with poor patient-reported outcomes (PROs), but the impact of steatosis is unknown. We aimed to evaluate the…”
    Get full text
    Journal Article